Načítá se...
Speech treatment in Parkinson's disease: Randomized controlled trial (RCT)
BACKGROUND: As many as 89% of people with Parkinson's disease (PD) develop speech disorders. OBJECTIVES: This randomized controlled trial evaluated two speech treatments for PD matched in intensive dosage and high‐effort mode of delivery, differing in subsystem target: voice (respiratory‐laryng...
Uloženo v:
| Vydáno v: | Mov Disord |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Inc.
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6261685/ https://ncbi.nlm.nih.gov/pubmed/30264896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.27460 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|